Literature DB >> 7009149

The stimulus-secretion coupling of glucose-induced insulin release. XLVII. The possible role of calmodulin.

I Valverde, A Sener, P Lebrun, A Herchuelz, W J Malaisse.   

Abstract

Pancreatic islets contain calmodulin. This protein activates adenylate cyclase in a subcellular fraction of rat islets in a calcium-dependent fashion. The Km for calmodulin was close to 0.1 microM, well below the concentration of endogenous calmodulin. Trifluoperazine and the trifluoromethylphenothiazine derivative of domperidone inhibited glucose-stimulated insulin release without affecting glucose oxidation by the islets. When insulin release was inhibited by 30% or more, this inhibition coincided with a reduction in the 45Ca net uptake by the islets. Both drugs suppressed the increment in adenylate cyclase activity evoked by calmodulin in a particulate fraction derived from the islets. However, the drugs also decreased basal and NaF-stimulated adenylate cyclase activities. Within limits, these data are compatible with the participation of endogenous calmodulin in the normal process of insulin release.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7009149     DOI: 10.1210/endo-108-4-1305

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  14 in total

1.  T-cell stimulation through the T-cell receptor/CD3 complex regulates CD2 lateral mobility by a calcium/calmodulin-dependent mechanism.

Authors:  S Q Liu; D E Golan
Journal:  Biophys J       Date:  1999-03       Impact factor: 4.033

2.  CGS 9343B and W7 (calmodulin antagonists) inhibit KCl-induced increase in cytosolic free calcium and insulin secretion of RINm5F cells.

Authors:  H Safayhi; M Kühn; I Koopmann; H P Ammon
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989 Jan-Feb       Impact factor: 3.000

3.  Evidence for calcium enhanced phosphorylation of pyruvate kinase by pancreatic islets.

Authors:  M J MacDonald; A Kowluru
Journal:  Mol Cell Biochem       Date:  1985-10       Impact factor: 3.396

Review 4.  Calmodulin and pancreatic B-cell function.

Authors:  I Valverde; W J Malaisse
Journal:  Experientia       Date:  1984-10-15

Review 5.  The role of cyclic AMP in insulin release.

Authors:  W J Malaisse; F Malaisse-Lagae
Journal:  Experientia       Date:  1984-10-15

6.  On the calcium receptor activating exocytosis: inhibitory effects of calmodulin-interacting drugs on rat mast cells.

Authors:  W W Douglas; E F Nemeth
Journal:  J Physiol       Date:  1982-02       Impact factor: 5.182

7.  Role of calmodulin in thyroid hormone stimulation in vitro of human erythrocyte Ca2+-ATPase activity.

Authors:  F B Davis; P J Davis; S D Blas
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

Review 8.  Calmodulin and insulin secretion.

Authors:  S Tomlinson; S W Walker; B L Brown
Journal:  Diabetologia       Date:  1982-01       Impact factor: 10.122

9.  Differential control of insulin secretion and somatostatin-receptor recruitment in isolated pancreatic islets.

Authors:  K E Sussman; H B Pollard; J W Leitner; R Nesher; J Adler; E Cerasi
Journal:  Biochem J       Date:  1983-07-15       Impact factor: 3.857

10.  Effects of desipramine, trifluoperazine and other inhibitors of calmodulin on the secretion of catecholamines from the adrenal medulla and postganglionic sympathetic nerves of the salivary gland.

Authors:  A R Wakade; T D Wakade
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-04       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.